PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)

This study has been completed.

Study NCT00274638 Information provided by Boehringer Ingelheim Pharmaceuticals

First Received: January 10, 2006 Last Updated: August 20, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	July 2003 (Final data collection date for primary outcome measure)